Our results showed the therapeutic ability of melatonin to control tumor growth and the metastatic process by targeting early migration, colony formation in breast cancer epithelial cell lines, and modulation of proteins belonging to the PI3K/AKT/mTOR pathway. Here, AKT1 is linked to neoplasm.